Acadia Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $384.5M
Liabilities Breakdown FY2017
Total Liabilities: $49.2M
Asset Breakdown
Total Assets: $384.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $69.4M | 18.1% |
| Accounts Receivable | $17.3M | 4.5% |
| Inventory | $5.2M | 1.4% |
| Property, Plant & Equipment | $2.7M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $5.5M | 1.4% |
| Other Assets | $284.3M | 73.9% |
Liabilities Breakdown
Total Liabilities: $49.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.8M | 17.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $40.4M | 82.1% |